Drug Survival of Risankizumab vs Other Biologics After 25 Months of Treatment Among Patients With Psoriatic Arthritis: An Interim Analysis of the VALUE Study. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s695. https://doi.org/10.25251/m10xva58